Fewer Acquisitions And Alliances In 2023, But Valuations Increased

 
• By Joseph Haas

INFOGRAPHIC: Deal volume for both M&A and alliances fell in 2023, but average valuations rose appreciably. Antibody-drug conjugates for cancer drove high-value acquisitions and partnerships.

Scrip Perspectives 2023/2024: 2023 Deals Overview
In both M&A and alliances, 2023 saw lower deal volume but higher deal valuations • Source: Shutterstock

More from Scrip Perspectives

More from Scrip